| 000 -LEADER |
|---|
| fixed length control field |
a |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190514115930.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
190322b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
AIKTC-KRRC |
| Transcribing agency |
AIKTC-KRRC |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
8196 |
| Author |
Bansal, Ramandeep |
| 245 ## - TITLE STATEMENT |
|---|
| Title |
Management of myasthenia gravis during pregnancy |
| 250 ## - EDITION STATEMENT |
|---|
| Volume, Issue number |
Vol.50 (6), Nov-Dec |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Mumbai |
| Name of publisher, distributor, etc. |
Wolter Kluwer |
| Year |
2018 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Pagination |
302-308p. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
The management of myasthenia gravis (MG) during pregnancy requires special skills as both diseases as well as its treatment can have deleterious effects on mother and fetus. MG often affects women in second and third decades of life during the childbearing age. Exacerbations of MG are likely to occur during the first trimester and postpartum period. The treatment of MG during pregnancy needs to be individualized depending on the severity of MG as well as the efficacy of various treatment modalities and their possible harmful effects on pregnancy. In addition, special attention has to be given to avoid drugs and other factors (such as urinary tract infections) which may worsen MG. The key to successful outcome during pregnancy in myasthenic women lies in multidisciplinary care involving obstetricians, neurologists, anesthetist as well as neonatologist. In this review, we discuss various therapeutic options available for the management of MG during pregnancy and provide recommendations based on the current best evidence. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| 9 (RLIN) |
4774 |
| Topical term or geographic name entry element |
PHARMACOLOGY |
| 653 ## - Keywords |
|---|
| Keywords |
Azathioprine |
| 653 ## - Keywords |
|---|
| Keywords |
myasthenia |
| 653 ## - Keywords |
|---|
| Keywords |
pregnancy |
| 653 ## - Keywords |
|---|
| Keywords |
pyridostigmine |
| 653 ## - Keywords |
|---|
| Keywords |
steroids |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
8197 |
| Co-Author |
Goyal, Manok Kumar |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
8198 |
| Co-Author |
Modi, Manish |
| 773 0# - HOST ITEM ENTRY |
|---|
| Title |
Indian Journal of Pharmacology |
| International Standard Serial Number |
0253-7613 |
| Place, publisher, and date of publication |
Andheri - Mumbai Wolters Kluwer India Private Limited |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| URL |
http://www.ijp-online.com/article.asp?issn=0253-7613;year=2018;volume=50;issue=6;spage=302;epage=308;aulast=Bansal |
| Link text |
Click Here |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Koha item type |
Articles Abstract Database |
